We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,323 hedge funds and large institutions have $72.9B invested in Thermo Fisher Scientific in 2018 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 512 increasing their positions, 492 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more first-time investments, than exits

New positions opened: 93 | Existing positions closed: 66

1% more funds holding

Funds holding: 1,3061,323 (+17)

4% more repeat investments, than reductions

Existing positions increased: 512 | Existing positions reduced: 492

0% more capital invested

Capital invested by funds: $72.6B → $72.9B (+$228M)

0.07% less ownership

Funds ownership: 87.63%87.56% (-0.07%)

6% less funds holding in top 10

Funds holding in top 10: 10599 (-6)

12% less call options, than puts

Call options by funds: $229M | Put options by funds: $260M

Holders
1,323
Holders Change
+17
Holders Change %
+1.3%
% of All Funds
30.28%
Holding in Top 10
99
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-5.71%
% of All Funds
2.27%
New
93
Increased
512
Reduced
492
Closed
66
Calls
$229M
Puts
$260M
Net Calls
-$30.8M
Net Calls Change
+$7M
Name Holding Trade Value Shares
Change
Change in
Stake
HPC
701
HM Payson & Co
Maine
$1.99M -$227K -1,071 -10%
CPIA
702
Cornell Pochily Investment Advisors
New York
$1.95M -$72.4K -341 -4%
CC
703
ClearArc Capital
Ohio
$1.91M +$15.1K +71 +0.8%
FMBTD
704
First Midwest Bank Trust Division
Illinois
$1.89M -$518K -2,442 -21%
JG
705
Jefferies Group
New York
$1.89M -$64.1K -302 -3%
FIM
706
Freedom Investment Management
Connecticut
$1.88M -$553K -2,605 -22%
IG
707
ING Group
Netherlands
$1.88M +$1.45M +6,828 +303%
OCM
708
Orser Capital Management
Texas
$1.88M -$83K -391 -4%
PCA
709
Providence Capital Advisors
North Carolina
$1.88M +$87.2K +411 +5%
TRCT
710
Tower Research Capital (TRC)
New York
$1.85M +$1.9M +8,950 New
TW
711
Transform Wealth
Colorado
$1.85M +$155K +728 +9%
ACP
712
Aviance Capital Partners
Florida
$1.85M -$15.3K -72 -0.8%
BHIA
713
Birch Hill Investment Advisors
Massachusetts
$1.84M +$446K +2,100 +31%
DC
714
Derby & Company
Massachusetts
$1.84M +$167K +785 +10%
PCA
715
Peddock Capital Advisors
Massachusetts
$1.83M -$1.06K -5 -0.1%
HCM
716
Highbridge Capital Management
New York
$1.82M +$1.86M +8,778 New
AI
717
Atria Investments
North Carolina
$1.8M +$16.8K +79 +0.9%
RIM
718
Regent Investment Management
Kentucky
$1.8M -$49.9K -235 -3%
LNWWM
719
Laird Norton Wetherby Wealth Management
California
$1.78M +$30.4K +143 +2%
AIM
720
Anchor Investment Management
South Carolina
$1.78M +$15.5K +73 +0.9%
ECM
721
EagleClaw Capital Management
Massachusetts
$1.78M -$21.2K -100 -1%
SSI
722
Scott & Selber Inc
Texas
$1.77M +$9.13K +43 +0.5%
SLF
723
Sun Life Financial
Ontario, Canada
$1.75M +$1.39M +6,536 +340%
SCA
724
Snowden Capital Advisors
New York
$1.75M +$17.2K +81 +1%
IRF
725
IBM Retirement Fund
New York
$1.75M -$234K -1,102 -12%

TMO Hedge Fund Activity: Q2 2018 in Review

1,323 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2018, worth a combined $72.9B — up 0.31% from $72.6B a quarter earlier.

Buyers outnumbered sellers: 93 funds opened new TMO positions and 66 closed out — a net gain of 27 holders — while 512 added to existing stakes and 492 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $343M. The largest seller was Deutsche Bank, cutting an estimated $298M.

  • 1,323 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2018, up from 1,306 in Q1 2018.
  • Funds reported $72.9B of Thermo Fisher Scientific stock for Q2 2018, up 0.31% quarter-over-quarter.
  • 93 funds opened new Thermo Fisher Scientific positions in Q2 2018 and 66 closed out, a net change of +27 holders.
  • The largest Thermo Fisher Scientific buyer in Q2 2018 was Viking Global Investors, an estimated $343M added.
  • The largest Thermo Fisher Scientific seller in Q2 2018 was Deutsche Bank, an estimated $298M sold.

Based on aggregated 13F filings for Q2 2018.